Nemera is a world leader in the design, development and manufacturing of drug delivery solutions for pharmaceutical, biotechnology & generics industri

With over 1,500 people and 4 plants across two continents, NEMERA is one of the world leaders in the design, development and manufacturing of drug delivery solutions.

NEMERA applies the same quality-oriented process to the development of proprietary devices and to customized solutions under contract with laboratories. The development quality team guarantees full compliance not only of the final device but of all the development chain. A strong program management ensures that the project is delivered on time and in budget.

Nemera’s expertise covers multiple modes of delivery:

  • OPHTHALMIC : Nemera offers a multi-dose closing tip system, Novelia®, which avoids the need for preservatives in the drug and prevents bacterial contamination over the duration of treatment.

Novelia® is an innovative, user friendly, preservative-free eye dropper with a precision blue tip, which is commercialized for both Medical Devices and Prescription drugs. It is recognized and appreciated by patients today across 4 continents. It is useful for applications for dry eyes, glaucoma, allergies and more.

  • NASAL, BUCCAL, AURICULAR : Nemera offers an extensive range of metered pumps and valves, compatible with a wide choice of actuators in different shapes and fitments for nasal, buccal and auricular delivery.

SP270+ is the new optimized spray pump engine for ear, nose and throat in terms of performance and raw materials.

Advancia® is the only breakthrough nasal spray pump in over ten years: it offers patients a user-friendly device and exceed regulatory requirements. Its unique user-independent feature guarantees a consistent spray and limits spray variations resulting from the patient’s method of use. A specific closing tip avoids any clogging and there is no metal part in contact with the drug. The Advancia® innovative project is co-financed by the European Union. Europe is committed in Normandy with the European Regional Development Fund (FEDER).

  • PARENTERAL: Nemera leverages decades of manufacturing and development experience in the parenteral device segment to offer patients premium products and customers a complete service.

Nemera has developed Safe’n’Sound®, a fully passive safety device for prefilled syringes to aid in the protection of healthcare professionals, patients who self-inject doctor prescribed medications, and individuals that assist self-injecting patients, from accidental needlesticks. Not only does Safe’n’Sound® improve users safety and injection conditions, but also the device complies with the recommendations of the World Health Organization and the EU Council Directive 2010/32/EU

  • DERMAL AND TRANSDERMAL: Nemera’s dermal delivery devices have been designed to ensure patient compliance thanks to precise and consistent dosing which is critical especially when applying formulations for systemic treatments.

Sof’Bag™ is a high performing airless pouch system for dermal and transdermal applications

Sof’Airless XS is a protective mini-airless system for small dose applications and sampling.

Sof’Airless XL is a customized dispenser for higher dose applications

  • PULMONARY: Nemera has a long-standing expertise in designing, developing and industrializing pulmonary devices.

Currently Offered
Anti-Counterfeiting Systems
Closure Systems
Contract Development
Dosing Syringes
Drug Delivery Devices
Fluid Handling
Folding Cartons
Glass Bottle
Inhalation Devices
Injection Devices
Injection Moulding
Insulin Pens
Isothermal Packaging
Measuring Spoons
Medical Devices
Multidose Eyedroppers
Plastic Bottle
Pre-Filled Syringes
Safety Systems for Prefilled Syringes
Security Seals
Single Dose
Tamper Evident
Tear Tapes
Tweets by MyPharmaPlace